The Future, page-90

Good post Tezzdog, thanks. When I read it I was a bit surprised as it sounds like Reqmed have the jump on PAR but from what I can ascertain its a slightly different path that they have taken tackling RA as opposed to strictly OA. The formulation also sounds a bit different ie involving human monoclonal antibody?

Here is a website with some more info on what it is, how it is to be taken and possible side effects: https://www.versusarthritis.org/about-arthritis/treatments/drugs/sarilumab/

I also had read that they are also involved in the Mt Sinai 'project', the link that Tezzdog provided also suggests that Reqmed and Paradigm might have various territories once the whole thing becomes approved, it sounds like a partnership of sorts?

Definitely do your own research and please add colour to this discussion if you can.